
BioUtah Presents at Medical Korea 2026
March 27, 2026
BioUtah president & CEO, Kelvyn Cullimoire, was invited by the Korean Health Industry Development Institute (KHIDI), an agency of the Korean Ministry of Health, to present at the Medical Korea conference on March 19-20, 2026. The topic of Cullimore’s presentation was “Why Utah is a preferred landing place for Korean medical device companies desiring to access the U.S. Market”. Cullimore also participated in a roundtable with key government, economic developement and industry representatives. Medical Korea is a major conference focusing on global business and attracting over 6,000 attendees from 50 countries.
BioUtah signed an MOU with KHIDI in November at the Utah Life Sciences Summit. Also attending was Seth Egan from Co-Diagnostics and Jihyun Kim & Tong-Soo Chung of World Trade Center Utah’s Korean office. The word on Utah as a sifnificant biotech hub is spreading worldwide.
Recent News
- BioUtah Members Named to TIME’s 2027 List of America’s Top Manufacturers
- CancerVax Successfully Kills Cancer Cells in Landmark Test
- SINTX Strengthens Patent Portfolio to Support International Growth Across Healthcare Markets
- Recursion Announces Alignment with FDA on Registrational Phase 3 Trial Design for REC-4881 in Familial Adenomatous Polyposis
- Myriad Genetics Expands SRL Partnership in Japan to Support Future Growth
- BioUtah’s 2026 Utah Life Sciences Summit Recap














